NASDAQ: GRALGrail Inc Stock Ownership - Who owns Grail?
Insider buying vs selling
Have Grail Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert P. Ragusa | Chief Executive Officer | 2025-12-03 | 1,604 | $97.28 | $156.04kSell |
| Joshua J. Ofman | President | 2025-12-03 | 13,000 | $100.00 | $1.30MSell |
| Aaron Freidin | Chief Financial Officer | 2025-12-03 | 25,000 | $99.15 | $2.48MSell |
| Robert P. Ragusa | Chief Executive Officer | 2025-12-03 | 14,807 | $94.43 | $1.40MSell |
| Robert P. Ragusa | Chief Executive Officer | 2025-12-03 | 15,356 | $95.28 | $1.46MSell |
| Robert P. Ragusa | Chief Executive Officer | 2025-12-03 | 8,233 | $96.22 | $792.15kSell |
| Aaron Freidin | Chief Financial Officer | 2025-11-17 | 1,697 | $79.20 | $134.40kSell |
| Illumina Inc | 10% Owner | 2025-11-17 | 1,000,000 | $79.85 | $79.85MSell |
| Joshua J. Ofman | President | 2025-10-16 | 6,114 | $82.01 | $501.41kSell |
| Robert P. Ragusa | Chief Executive Officer | 2025-10-15 | 7,239 | $68.88 | $498.62kSell |
GRAL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GRAL insiders and whales buy or sell their stock.
GRAL Shareholders
What type of owners hold Grail Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Illumina Inc | 8.98% | 3,502,126 | $332.91M | Insider |
| Chun R. Ding | 8.48% | 3,305,055 | $314.18M | Insider |
| Blackrock Inc | 6.32% | 2,464,712 | $234.30M | Institution |
| Primecap Management Co | 5.18% | 2,020,940 | $192.11M | Institution |
| Crcm LP | 4.73% | 1,842,651 | $175.16M | Institution |
| Vanguard Group Inc | 4.66% | 1,816,993 | $172.72M | Institution |
| Baker Bros Advisors LP | 4.18% | 1,630,125 | $154.96M | Institution |
| Farallon Capital Management LLC | 3.46% | 1,349,000 | $128.24M | Institution |
| State Street Corp | 3.38% | 1,316,977 | $125.19M | Institution |
| Arbiter Partners Capital Management LLC | 2.66% | 1,035,897 | $98.47M | Institution |
GRAL vs Diagnostic & Research Stocks
Grail Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.